Dorsal root ganglion RFA is used to treat radiculopathy. There are multiple applications of pulsed RFA in the treatment of chronic pain.

Vertex Pharmaceuticals (NASDAQ: VRTX) is a biotechnology company with a strong track record of success in developing ...

The following is a summary of “Are Stabilisation Exercises Effective After Epidural Steroid Injection in Patients With ...

About the Phase 2 Suzetrigine Lumbosacral Radiculopathy (LSR ... under priority review by the FDA for the treatment of moderate-to-severe acute pain with a Prescription Drug User Fee Act (PDUFA ...

Vertex Pharmaceuticals shares sank Thursday after the company reported mixed results in a Phase 2 drug trial to treat ...

highly selective NaV1.8 pain signal inhibitor in people with painful lumbosacral radiculopathy, or LSR. The study met its primary endpoint with statistically significant and clinically meaningful ...

Most Americans will endure some form of back pain in their life. Spine, back, and neck problems are most common with neck and ...

The study tested the NaV1.8 pain signal inhibitor suzetrigine in 102 people with painful lumbosacral radiculopathy (LSR ... 2.02 points after 12 weeks of treatment with suzetrigine, causing ...

Dorsal root ganglion RFA is used to treat radiculopathy. There are multiple applications of pulsed RFA in the treatment of chronic pain.

highly selective NaV1.8 pain signal inhibitor in people with painful lumbosacral radiculopathy (LSR). The study met its primary endpoint with statistically significant and clinically meaningful ...

the suzetrigine arm within-group reduction in pain was similar to the overall study and had greater separation from the placebo arm. These analyses suggest that trial design innovation may better ...